The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, March 30, 2026 /PRNewswire/ -- The Texas Healthcare & Bioscience Institute (THBI), the statewide public ...
More than 100 Butler County leaders, school officials, teachers and high school students saw the official opening ceremony ...
Kaleido Biosciences Inc. company and executive profile by Barron's. View the latest KLDO company infomation and executive ...
Earlier this month, at the Texas Healthcare & Bioscience Institute Life Sciences Summit in Austin, the state’s rising stature ...
Artelo Biosciences, Inc. ARTL shares jumped on Monday after the company announced the publication of a peer‑reviewed article ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of ...
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to ...
The Phase 2a study results revealed that VIS-101 produced rapid and durable treatment responses with both 3 mg and 6 mg dose cohorts in patients with wet age-related macular degeneration (wet AMD).
Skye Bioscience Inc. (NASDAQ:SKYE) stock sank on Monday after the company released topline data from its 26-week Phase 2a CBeyond proof-of-concept study of nimacimab. The nimacimab monotherapy arm did ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
AUSTIN, Texas, March 30, 2026 /PRNewswire/ -- The Texas Healthcare & Bioscience Institute (THBI), the statewide public policy voice of the healthcare and bioscience industry, today released a ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results